Form EFFECT InMed Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 1, 2026 4:01 P.M. |
| Form: | S-4 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dogecoin Price Prediction: Dogecoin Labs Unites Teams Behind 500,000-User Wallet as Remittix Earn Targets Up to 22% APY
- Crypto Market News: Bitcoin Near $81,500 as $33M Remittix Prepares a 41-Currency PayFi Expansion
- Ethereum Price Prediction: October ETF Outflows Top $1B as Remittix Earn Prepares Aave, Morpho and Maple Finance Pools
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share